Dr Calvo talks on how molecular genetics is changing the way in which cancer should be consider in regards to providing the best treatment to the each patient; also, a discussion on how a large number of cancers can be grouped for specific treatment and the reverse, very specific types of cancers, but with similar molecular abnormalities. Dr Calvo also addresses multiple drug treatments and the objectives for the upcoming year at the French National Cancer Institute.